Elanco Animal Health (ELAN) Net Cash Flow (2017 - 2026)

Elanco Animal Health has disclosed Net Cash Flow across 10 years of filings, most recently posting -$112.0 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$112.0 million, down 1020.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$96.0 million (down 151.89% YoY), and the FY2025 annual result was $6.0 million, down 97.1% from the prior year.
• Net Cash Flow came in at -$112.0 million for Q1 2026 at Elanco Animal Health, down from $26.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $179.0 million in Q2 2022 to a low of -$291.0 million in Q1 2022.
• The 5-year median for Net Cash Flow is $5.0 million (2023), against an average of -$9.2 million.
• Across the five-year window, Net Cash Flow surged 1220.0% in 2024 and plunged 1020.0% in 2026, its largest moves.
• Elanco Animal Health's Net Cash Flow stood at -$147.0 million in 2022, then surged by 88.44% to -$17.0 million in 2023, then soared by 423.53% to $55.0 million in 2024, then plunged by 52.73% to $26.0 million in 2025, then slumped by 530.77% to -$112.0 million in 2026.
• The last three Net Cash Flow figures came in at -$112.0 million (Q1 2026), $26.0 million (Q4 2025), and -$35.0 million (Q3 2025), per Business Quant data.